Stock REKA REKAH PHARMACEUTICAL INDUSTRY LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Rekah Pharmaceutical Industry Ltd.

Equities

REKA

IL0010810096

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 07:24:09 2024-04-25 am EDT 		5-day change 1st Jan Change
1,311 ILa -4.10% Intraday chart for Rekah Pharmaceutical Industry Ltd. +2.42% -11.30%
Mar. 26 Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Rekah Pharmaceutical Industry Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Business Summary

Rekah Pharmaceutical Industry Ltd. (Rekah) is an Israel-based company which operates directly and through its subsidiaries. The Company operates two Good Manufacturing Practice (GMP) approved manufacturing sites, it has a marketing and distribution arm, a chain of pharmacies, and an export import unit. Rekah's plant covers approximately 5,000 square meters and was designed to take advantage of the most advanced and automated packaging techniques available. In April 1995, Rekah received the approval of the Ministry of Health for its new facility. The sterile department was designed to meet the standard of the United States Food and Drug Administration and was opened in February 1997. The Company distributes its products through Ophir & Shalpharm to institutional users such as Israel Health Funds, hospitals and government health facilities. Other subsidiaries include Vitamed Pharmaceutical Industry Ltd., CenterPharm, RITE, Talmor, BARBARA WOLF Ltd. and Madad.

Number of employees: 427

Sales per Business

ILS in Million2021Weight2022Weight Delta
Core Products
64.8 %
161 60.9 % 190 64.8 % +17.90%
Distribution Special
29.8 %
88 33.5 % 87 29.8 % -1.33%
Other
5.4 %
15 5.6 % 16 5.4 % +5.64%

Sales per region

ILS in Million2021Weight2022Weight Delta
Israel
100.0 %
264 100.0 % 292 100.0 % +10.78%

Managers

Managers TitleAgeSince
Mordechai Algrably CEO
 Chief Executive Officer 80 93-08-23
Yuval Bernshtein DFI
 Director of Finance/CFO 44 18-10-31
Georgette T. Algrably BRD
 Director/Board Member 78 93-08-23
Jack Azran PRN
 Corporate Officer/Principal - -
Guy Zangi SAM
 Sales & Marketing 51 18-09-12
Yuval Elgrably PRN
 Corporate Officer/Principal 47 11-03-30
Ronit Zelnik PRN
 Corporate Officer/Principal 66 97-01-08
Joseph Ginossar AUD
 Comptroller/Controller/Auditor 65 14-06-14

Members of the board

Members of the board TitleAgeSince
Ishay Davidi BRD
 Director/Board Member 62 15-04-14
Amiram Boehm BRD
 Director/Board Member 52 15-04-14
Avraham Bigger CHM
 Chairman 77 15-04-14
Mordechai Algrably CEO
 Chief Executive Officer 80 93-08-23
Georgette T. Algrably BRD
 Director/Board Member 78 93-08-23
Orly Silberman BRD
 Director/Board Member 64 15-04-14
Udi Nissan Nisan BRD
 Director/Board Member 55 16-10-31
Arnon Zuaretz BRD
 Director/Board Member 69 16-10-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,523,922 2,000,627 ( 17.36 %) 19,900 ( 0.1727 %) 17.36 %

Shareholders

NameEquities%Valuation
First Israel Mezzanine Investors Ltd.
42.66 %
4,915,784 42.66 % 18 M ILa
Mordechai Algrably
15.17 %
1,748,439 15.17 % 7 M ILa
Georgette T. Algrably
15.17 %
1,748,439 15.17 % 7 M ILa
Udi Dor
6.876 %
792,374 6.876 % 3 M ILa
Helen Dor
2.710 %
312,329 2.710 % 1 M ILa
Excellence Nessuah Mutual Funds Management Ltd.
1.196 %
137,808 1.196 % 517 575 ILa
IBI Mutual Funds Management (1978) Ltd.
1.151 %
132,685 1.151 % 498 334 ILa
Vitamed Pharmaceutical Industries Ltd.
0.9483 %
109,286 0.9483 % 410 453 ILa
Lamashkia Mutual Funds Management Co. (1982) Ltd.
0.4900 %
56,464 0.4900 % 212 066 ILa
Ramco Mutual Funds Management (1989) Ltd.
0.3471 %
40,000 0.3471 % 150 231 ILa

Company contact information

Rekah Pharmaceutical Industry Ltd.

30 Hamelacha Street

5881904, Holon

+

http://www.rekah.co.il
address Rekah Pharmaceutical Industry Ltd.(REKA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
REKAH PHARMACEUTICAL INDUSTRY LTD. Stock Rekah Pharmaceutical Industry Ltd.
-11.30% 39.24M
MCKESSON CORPORATION Stock McKesson Corporation
+17.35% 71.39B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
+2.39% 25.1B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+5.38% 8.59B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+6.69% 8.19B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-20.96% 7.91B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+0.49% 4.54B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+17.12% 4.31B
GALENICA AG Stock Galenica AG
-2.61% 3.86B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+22.08% 3.64B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. REKA Stock
  4. Company Rekah Pharmaceutical Industry Ltd.